Ciliary Neurotrophic Factor - A Promising New Therapy for Macular Telangiectasia Type 2.

Saved in:
Bibliographic Details
Title: Ciliary Neurotrophic Factor - A Promising New Therapy for Macular Telangiectasia Type 2.
Authors: Duncan JL; Department of Ophthalmology, University of California, San Francisco, San Francisco.
Source: NEJM evidence [NEJM Evid] 2025 Aug; Vol. 4 (8), pp. EVIDe2500127. Date of Electronic Publication: 2025 Jul 22.
Publication Type: Editorial
Journal Info: Publisher: NEJM Group, a division of the Massachusetts Medical Society Country of Publication: United States NLM ID: 9918317485806676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2766-5526 (Electronic) Linking ISSN: 27665526 NLM ISO Abbreviation: NEJM Evid Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:2766-5526
DOI:10.1056/EVIDe2500127